Various alphabetized medical records

Life Sciences Securities Litigation

CRA has a broad range of experience in complex shareholder lawsuits and appraisal disputes involving life sciences and healthcare companies. CRA assists clients across all phases of the securities litigation process, including responding to pre-litigation SEC investigations, class certification, discovery, materiality, loss causation, damages, and settlement negotiations. CRA supports clients in disputes arising from mergers and acquisitions by providing industry expertise in evaluating claims regarding drug development and commercialization and other issues. Our experts provide valuation opinions related appraisal lawsuits brought by dissenter or minority shareholders, and estimated damages related to shareholder disputes for breach of contingent valuation rights agreements.


  • 01
    CRA assesses pharmaceutical investor claims in Delaware Chancery Court
    In a matter before the Delaware Chancery Court, CRA was retained on behalf of a pharmaceutical company facing an investor suit alleging breach of fiduciary...
    View engagement
  • 02
    CRA evaluates commercial efforts to develop a MS drug with respect contractual obligations following merger
    CRA assessed commercial efforts to develop and commercialize a MS drug with respect to obligations stemming from the acquisition of Genzyme Corporation by...
    View engagement

Subscribe to receive our latest Insights.